Sika Interplant Systems Limited Fundamental Analysis (BSE: SIKA.BO)
Sika Interplant Systems Limited Fundamental Analysis (BSE: SIKA.BO)
Sika Interplant Systems Limited (BSE: SIKA.BO) shows moderate financial fundamentals with a PE ratio of 65.91, profit margin of 17.33%, and ROE of 25.46%. The company generates $2.1B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 78.7/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze SIKA.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentSIKA.BO demonstrates superior asset utilization.
Valuation Score
ModerateSIKA.BO shows balanced valuation metrics.
Growth Score
ModerateSIKA.BO shows steady but slowing expansion.
Financial Health Score
ExcellentSIKA.BO maintains a strong and stable balance sheet.
Profitability Score
ModerateSIKA.BO maintains healthy but balanced margins.
Key Financial Metrics
Is SIKA.BO Expensive or Cheap?
P/E Ratio
SIKA.BO trades at 65.91 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, SIKA.BO's PEG of 1.73 indicates fair valuation.
Price to Book
The market values Sika Interplant Systems Limited at 15.52 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 49.97 times EBITDA. This signals the market has high growth expectations.
How Well Does SIKA.BO Make Money?
Net Profit Margin
For every $100 in sales, Sika Interplant Systems Limited keeps $17.33 as profit after all expenses.
Operating Margin
Core operations generate 20.88 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $25.46 in profit for every $100 of shareholder equity.
ROA
Sika Interplant Systems Limited generates $20.90 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Sika Interplant Systems Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Sika Interplant Systems Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
SIKA.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
65.91
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
1.73
vs 25 benchmark
P/B Ratio
Price to book value ratio
15.52
vs 25 benchmark
P/S Ratio
Price to sales ratio
11.43
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.42
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.25
vs 25 benchmark
ROA
Return on assets percentage
0.21
vs 25 benchmark
ROCE
Return on capital employed
0.27
vs 25 benchmark
How SIKA.BO Stacks Against Its Sector Peers
| Metric | SIKA.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 65.91 | 30.52 | Worse (Expensive) |
| ROE | 25.46% | 1172.00% | Weak |
| Net Margin | 17.33% | -20786.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.38 | Strong (Low Leverage) |
| Current Ratio | 3.42 | 24.22 | Strong Liquidity |
| ROA | 20.90% | -1311221.00% (disorted) | Strong |
SIKA.BO outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Sika Interplant Systems Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
EPS CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
FCF CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure